Sudden Cardiac Death : Lessons Learned from Cardiac Implantable Rhythm Devices - 23/11/17
, Andrew E. Epstein, MD, FHRSRésumé |
Trials have demonstrated that implantable–cardioverter defibrillators (ICDs) are effective in preventing sudden cardiac death (SCD). The degree of left ventricular dysfunction is the only parameter to identify primary prevention populations at higher risk of SCD in which ICDs may reduce longitudinal mortality risk. Clinical application of current stratification approaches based on left ventricular ejection fraction (LVEF) alone has failed to prevent most SCD in the general population. This lack of specificity has resulted in a significant number of potentially unnecessary ICDs. Future studies should focus on newer risk markers to improve the predictive value of LVEF and SCD prevention.
Le texte complet de cet article est disponible en PDF.Keywords : Sudden cardiac death, Implantable rhythm devices, Cardiac arrest, Left ventricular dysfunction, Left ventricular ejection fraction, Implantable cardioverter-defibrillator
Plan
Vol 9 - N° 4
P. 749-759 - décembre 2017 Retour au numéro
Article précédent
- Neuromuscular Disease : Cardiac Manifestations and Sudden Death Risk
- Worawan Limpitikul, Chin Siang Ong, Gordon F. Tomaselli
- Primary Prevention Implantable Cardiac Defibrillator Trials : What Have We Learned?
- Jakub Sroubek, Alfred E. Buxton
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?